source
- Supreme Court grants three-day extension on ruling over abortion drug mifepristoneThe U.S. Supreme Court announced it will take an additional three days before issuing a decision in the case concerning the abortion medication mifepristone. The case, Louisiana v. FDA, reached th…
- Alkermes reports Phase 3 success for Lumryz; Boehringer announces antibody partnershipAlkermes announced that its narcolepsy medication Lumryz, which received regulatory approval in 2023, achieved its primary efficacy endpoint in a Phase 3 trial. The study met the predefined criter…